Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

16 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pharmacokinetics of vancomycin in patients with various degrees of renal function.
Matzke GR, McGory RW, Halstenson CE, Keane WF. Matzke GR, et al. Among authors: mcgory rw. Antimicrob Agents Chemother. 1984 Apr;25(4):433-7. doi: 10.1128/aac.25.4.433. Antimicrob Agents Chemother. 1984. PMID: 6732213 Free PMC article.
Safety profile, pharmacokinetics, and pharmacodynamics of siplizumab, a humanized anti-CD2 monoclonal antibody, in renal allograft recipients.
Pruett TL, McGory RW, Wright FH, Pescovitz MD, Yang H, McClain JB. Pruett TL, et al. Among authors: mcgory rw. Transplant Proc. 2009 Nov;41(9):3655-61. doi: 10.1016/j.transproceed.2009.06.226. Transplant Proc. 2009. PMID: 19917362
Hepatitis B immune globulin: the US experience.
Pruett TL, McGory R. Pruett TL, et al. Clin Transplant. 2000;14 Suppl 2:7-13. Clin Transplant. 2000. PMID: 10965958
Hepatitis B immune globulin dose requirements following orthotopic liver transplantation for chronic hepatitis B cirrhosis.
McGory R, Ishitani M, Oliveira W, Stevenson W, McCullough C, Pruett T. McGory R, et al. Transplant Proc. 1996 Jun;28(3):1687-8. Transplant Proc. 1996. PMID: 8658840 No abstract available.
Pharmacoeconomic analysis of HBV liver transplant therapies.
McGory R. McGory R. Clin Transplant. 2000;14 Suppl 2:29-38. Clin Transplant. 2000. PMID: 10965962
Significance of isolated pretransplant hepatitis B anticore antibody.
Caldwell SH, Ishitani MB, Gaffey MJ, Shepard BL, McGory R, Pruett TL. Caldwell SH, et al. Transplant Proc. 1997 Nov;29(7):2846-7. doi: 10.1016/s0041-1345(97)00702-1. Transplant Proc. 1997. PMID: 9365586 No abstract available.
Successful retransplantation for recurrent posttransplant hepatitis B virus infection in the primary allograft.
Ishitani M, McGory R, Dickson R, Caldwell S, Bickston S, McCullough C, Pruett T. Ishitani M, et al. Transplant Proc. 1996 Jun;28(3):1714-6. Transplant Proc. 1996. PMID: 8658852 No abstract available.
Retransplantation of patients with severe posttransplant hepatitis B in the first allograft.
Ishitani M, McGory R, Dickson R, Caldwell S, Bickston S, McCullough C, Pruett T, Terrault N, Roberts J, Ascher N, Wright T, Lake J. Ishitani M, et al. Transplantation. 1997 Aug 15;64(3):410-4. doi: 10.1097/00007890-199708150-00006. Transplantation. 1997. PMID: 9275104
Prevention of hepatitis B "rerecurrence" after a second liver transplant--the role of maintenance polyclonal HBIG therapy.
Kiyasu PK, Ishitani MB, McGory RW, Gaffey MJ, Dickson RC, Caldwell SH, Stevenson WS, Pruett TL. Kiyasu PK, et al. Among authors: mcgory rw. Transplantation. 1994 Oct 27;58(8):954-6. doi: 10.1097/00007890-199410270-00018. Transplantation. 1994. PMID: 7940743 No abstract available.
Effects of fialuridine on hepatitis B immune globulin pharmacokinetics following orthotopic liver transplant for chronic hepatitis B viral-induced cirrhosis.
McGory RW, Ishitani MB, Oliveira WM, Stevenson WC, Dickson RC, Caldwell SH, Pruett TL. McGory RW, et al. Transplant Proc. 1995 Feb;27(1):1213-4. Transplant Proc. 1995. PMID: 7878854 No abstract available.
16 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback